These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37268851)

  • 1. PD1 agonist antibody passes first phase II trial for autoimmune disease.
    Mullard A
    Nat Rev Drug Discov; 2023 Jul; 22(7):526. PubMed ID: 37268851
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies in the immunotherapy of autoimmune diseases.
    Perosa F; Luccarelli G; Prete M; Dammacco F
    Ann Ital Med Int; 2001; 16(4):220-32. PubMed ID: 11799630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-CD20 antibody for the treatment of systemic autoimmune diseases].
    Tanaka Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Feb; 27(1):28-33. PubMed ID: 15045813
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial watch: BLYS-targeted antibody shows promise in Phase III SLE trial.
    Nat Rev Drug Discov; 2009 Sep; 8(9):688. PubMed ID: 19721439
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug evaluation: CNTO-1275, a mAb against IL-12/IL-23p40 for the potential treatment of inflammatory diseases.
    Wittig BM
    Curr Opin Investig Drugs; 2007 Nov; 8(11):947-54. PubMed ID: 17979029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fontolizumab Protein Design Labs.
    Dumont FJ
    Curr Opin Investig Drugs; 2005 May; 6(5):537-44. PubMed ID: 15912969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New approaches to treatment in immunology with monoclonal antibodies].
    Rubbert A; Diehl V
    Internist (Berl); 2001 Jun; 42(6):843, 846-53. PubMed ID: 11449631
    [No Abstract]   [Full Text] [Related]  

  • 8. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases.
    Ding C; Xu J; Li J
    Curr Opin Investig Drugs; 2008 May; 9(5):515-22. PubMed ID: 18465662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current situations and the future prospect of monoclonal antibody products].
    Yamaguchi T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):36-46. PubMed ID: 25707201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rituximab in two unusual antibody-mediated autoimmune disorders.
    Adler M; Soliotis F; Thakrar S; Stratton R
    J R Soc Med; 2005 Jun; 98(6):271-2. PubMed ID: 15928379
    [No Abstract]   [Full Text] [Related]  

  • 11. Current methods for the generation of human antibodies for the treatment of autoimmune diseases.
    Osbourn J; Jermutus L; Duncan A
    Drug Discov Today; 2003 Sep; 8(18):845-51. PubMed ID: 12963321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective antibodies against HSP60 for autoimmune inflammatory diseases.
    Ulmansky R; Naparstek Y
    Clin Immunol; 2018 Jan; 186():63. PubMed ID: 28751270
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease.
    Prete M; Perosa F; Favoino E; Dammacco F
    Clin Exp Med; 2005 Dec; 5(4):141-60. PubMed ID: 16362794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of systemic autoimmune and inflammatory diseases with rituximab].
    Bussone G; Hachulla E; Sibilia J; Michel M; Godeau B; Guillevin L; Mouthon L
    Presse Med; 2009 May; 38(5):808-23. PubMed ID: 19297127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of rituximab on immunocompetency in patients with autoimmune disease.
    Looney RJ; Srinivasan R; Calabrese LH
    Arthritis Rheum; 2008 Jan; 58(1):5-14. PubMed ID: 18163518
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospects for B-cell-targeted therapy in autoimmune disease.
    Edwards JC; Cambridge G
    Rheumatology (Oxford); 2005 Feb; 44(2):151-6. PubMed ID: 15509628
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab.
    Doan T; Massarotti E
    Drugs Today (Barc); 2005 Dec; 41(12):785-97. PubMed ID: 16474854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The therapy with monoclonal antibodies].
    Martini A
    Minerva Pediatr; 2009 Dec; 61(6):779-81. PubMed ID: 19935550
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases].
    Hansen PB; Hasselbalch HC
    Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710
    [No Abstract]   [Full Text] [Related]  

  • 20. [CD20 antibody for the treatment of systemic autoimmune diseases].
    Tanaka Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.